Huffpost Business

At 4 Mil Yearly Injections, Botox Is Cash Cow For Allergan

Posted: Updated:

In his corner office, Mr. Botox looked his age.

He hadn't had a shot of botulinum toxin in a while, and the furrow between his brows was back.

"You would never know I'm really 75 years old," David E.I. Pyott said, trotting out a well-worn joke that he likes to make "because of who I am."

He's the man who made a muscle-controlling poison the most fashionable weapon against aging. And he's really 54.

When Allergan Inc. hired him as chief executive in 1998, it was generating annual revenue of $1.26 billion turning out nasal sprays, eyedrops and optical devices. It still makes eyedrops but otherwise doesn't much look like the company founded in an Irvine bean patch 60 years ago.

Read entire article here.